A major milestone for Baymatob and for maternal health innovation!
We are thrilled to announce that patient recruitment has officially begun in the United States for the pivotal clinical trial of out Oli-PPH Early Warning System.
Launching recruitment in the U.S. marks a significant step forward as we work to validate Oli’s ability to provide early warning of postpartum hemorrhage—the leading cause of preventable maternal death worldwide. This milestone reflects years of dedicated effort from our engineering, clinical, regulatory, and research partners across the globe.
We are honoured to be collaborating with the exceptional clinicians and researchers at Woman’s Hospital in Baton Rouge, Louisiana, and are deeply grateful to the patients and families who are contributing to this transformative study.
Thank you to our partners, advisors, investors, and supporters who continue to help bring this vision to life. Each step moves us closer to delivering a safer, more informed childbirth experience for mothers, babies, and clinicians.
